Silence Therapeutics plc Foreign Exchange Loss
Silence Therapeutics plc (SLNCF) reported Foreign Exchange Loss of GBP 1.02 million for the 1-month period ending 2021-05-31, per its 20-F filed 2023-03-15.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:ForeignExchangeLoss · last filed 2023-03-15
- 2021-05-31: Foreign Exchange Loss 1 month 1.02M GBP.
| Period end | Foreign Exchange Loss 1 month |
|---|---|
| 2021-05-31 | 1.02M GBP 20-F · filed 2023-03-15 |